GLP-1 agonist medications such as Ozempic and Wegovy are in high demand ... 53 percent lower risk of liver cancer, 48 percent lower risk of ovarian cancer, 46 percent lower risk of colorectal ...

Fifty years of outstanding neuroscience research studies have revealed many secrets of how drugs of abuse affect and change ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

Head of the Metabolic Neuroscience Laboratory, investigates the brain ‘goo’ behind obesity and Type-2 diabetes - and how we ...